ArticleFrontiers in neurology2022

Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis.

Yiming Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.